Alzheimer’s disease is a progressive disease that destroys memory and other important mental functions.
It’s the most common cause of dementia — a group of brain disorders that results in the loss of intellectual and social skills. These changes are severe enough to interfere with day-to-day life.
In Alzheimer’s disease, the connections between brain cells and the brain cells themselves degenerate and die, causing a steady decline in memory and mental function.
About this research study
If you suffer from Alzheimer’s disease or care for someone that does, then you know that memory loss is only one symptom of this debilitating disease that affects four million Americans and their families. A research study testing the effectiveness of an investigational medication for treating mild to moderate Alzheimer’s is now underway at Richmond Behavioral Associates in Staten Island.
The participant must have a confirmed diagnosis of Alzheimer’s Disease
The participant must have a caregiver who can accompany them to all study appointments
Study Participants Will Receive:
All study-related evaluations, physical exams and follow up visits at no cost
All study medication at no cost
Possible compensation for their time and travel